Trexquant Investment LP Atri Cure, Inc. Transaction History
Trexquant Investment LP
- $8.01 Billion
- Q1 2025
A detailed history of Trexquant Investment LP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 275,548 shares of ATRC stock, worth $9.42 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
275,548
Previous 98,206
180.58%
Holding current value
$9.42 Million
Previous $3 Million
196.2%
% of portfolio
0.11%
Previous 0.04%
Shares
18 transactions
Others Institutions Holding ATRC
# of Institutions
238Shares Held
52MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$161 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$158 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$126 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$103 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$83.3 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.59B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...